ATE380823T1 - Rekombinante adhesin-proteine aus haemophilus influenzae - Google Patents
Rekombinante adhesin-proteine aus haemophilus influenzaeInfo
- Publication number
- ATE380823T1 ATE380823T1 AT00910463T AT00910463T ATE380823T1 AT E380823 T1 ATE380823 T1 AT E380823T1 AT 00910463 T AT00910463 T AT 00910463T AT 00910463 T AT00910463 T AT 00910463T AT E380823 T1 ATE380823 T1 AT E380823T1
- Authority
- AT
- Austria
- Prior art keywords
- haemophilus influenzae
- adhesin proteins
- recombinant adhesin
- typeable
- recombinant
- Prior art date
Links
- 241000606768 Haemophilus influenzae Species 0.000 title abstract 3
- 229940047650 haemophilus influenzae Drugs 0.000 title abstract 3
- 108010037896 heparin-binding hemagglutinin Proteins 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/268,347 US6335182B1 (en) | 1999-03-16 | 1999-03-16 | Recombinant Haemophilus influenzae adhesin proteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE380823T1 true ATE380823T1 (de) | 2007-12-15 |
Family
ID=23022574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00910463T ATE380823T1 (de) | 1999-03-16 | 2000-03-16 | Rekombinante adhesin-proteine aus haemophilus influenzae |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6335182B1 (enExample) |
| EP (3) | EP1903055A3 (enExample) |
| JP (3) | JP2004529601A (enExample) |
| AT (1) | ATE380823T1 (enExample) |
| AU (1) | AU772007B2 (enExample) |
| CA (1) | CA2364667A1 (enExample) |
| DE (1) | DE60037413T2 (enExample) |
| MX (1) | MXPA01009335A (enExample) |
| NZ (2) | NZ514606A (enExample) |
| WO (1) | WO2000055191A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7785609B1 (en) | 1999-03-16 | 2010-08-31 | Sanofi Pasteur Limited | Recombinant Haemophilus influenzae adhesin proteins |
| CA2379400A1 (en) * | 1999-07-27 | 2001-02-01 | Aventis Pasteur Limited | Recombinant high molecular weight major outer membrane protein of moraxella |
| US7015033B1 (en) * | 2000-05-25 | 2006-03-21 | Aventis Pasteur Limited | Co-expression of recombination proteins |
| US10279026B2 (en) | 2012-04-26 | 2019-05-07 | Glaxosmithkline Biologicals Sa | Antigens and antigen combinations |
| MX374919B (es) | 2012-04-26 | 2025-03-06 | Glaxosmithkline Biologicals S A Star | ANTÍGENOS Y COMBINACIONES DE ANTÍGENOS PARA USARSE PARA ELEVAR LA RESPUESTA INMUNE CONTRA Haemophilus influenzae. |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE216826C (enExample) | ||||
| US4258029A (en) | 1979-04-23 | 1981-03-24 | Connaught Laboratories Limited | Synthetic adjuvants for stimulation of antigenic responses |
| US4496538A (en) | 1982-07-06 | 1985-01-29 | Connaught Laboratories, Inc. | Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine |
| US4952496A (en) | 1984-03-30 | 1990-08-28 | Associated Universities, Inc. | Cloning and expression of the gene for bacteriophage T7 RNA polymerase |
| DE3521994A1 (de) | 1985-06-20 | 1987-01-02 | Bayer Ag | N-(2-aminoacylamido-2-desoxy-hexosyl)-amide-, -carbamate und -harnstoffe, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
| US5194254A (en) | 1986-05-06 | 1993-03-16 | Connaught Laboratories Limited | Enhancement of antigen immunogenicity |
| US5843463A (en) | 1990-12-21 | 1998-12-01 | Antexbiologics, Inc. | Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae |
| JP3296817B2 (ja) | 1991-04-02 | 2002-07-02 | バイオテック・オーストラリア・ピーティーワイ・リミテッド | 微粒子に適した経口配布系 |
| AU686660B2 (en) * | 1993-08-11 | 1998-02-12 | Jenner Technologies | Prostatic cancer vaccine |
| WO1995005853A1 (en) * | 1993-08-26 | 1995-03-02 | The Regents Of The University Of California | Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides |
| US6361779B1 (en) * | 1993-11-08 | 2002-03-26 | Aventis Pasteur Limited | Transferrin receptor genes |
| US6764682B1 (en) | 1994-06-16 | 2004-07-20 | Aventis Pasteur Limited | Adjuvant compositions containing more than one adjuvant |
| DE69534747T2 (de) | 1994-07-19 | 2006-07-06 | Wyeth Holdings Corp. | Haemophilus influenzae (nt hi) lkp tip adhesin protein und nukleinsäure |
| US5646259A (en) | 1995-03-24 | 1997-07-08 | St. Louis University | DNA encoding haemophilus adhesion proteins |
| US6335018B1 (en) | 1995-05-01 | 2002-01-01 | Aventis Pasteur Limited | High molecular weight major outer membrane protein of moraxella |
| JP3203160B2 (ja) * | 1995-08-09 | 2001-08-27 | 三菱電機株式会社 | ボリューム・レンダリング装置及び方法 |
| US6342232B1 (en) * | 1999-03-03 | 2002-01-29 | Aventis Pasteur Limited | Multi-component vaccine comprising at least three antigens to protect against disease cased by Haemophilus influenzae |
-
1999
- 1999-03-16 US US09/268,347 patent/US6335182B1/en not_active Expired - Fee Related
-
2000
- 2000-03-16 EP EP07021386A patent/EP1903055A3/en not_active Withdrawn
- 2000-03-16 AT AT00910463T patent/ATE380823T1/de active
- 2000-03-16 CA CA002364667A patent/CA2364667A1/en not_active Abandoned
- 2000-03-16 NZ NZ514606A patent/NZ514606A/en not_active IP Right Cessation
- 2000-03-16 DE DE60037413T patent/DE60037413T2/de not_active Expired - Lifetime
- 2000-03-16 AU AU32680/00A patent/AU772007B2/en not_active Ceased
- 2000-03-16 NZ NZ530979A patent/NZ530979A/en not_active IP Right Cessation
- 2000-03-16 JP JP2000605617A patent/JP2004529601A/ja not_active Withdrawn
- 2000-03-16 MX MXPA01009335A patent/MXPA01009335A/es active IP Right Grant
- 2000-03-16 EP EP00910463A patent/EP1180119B1/en not_active Expired - Lifetime
- 2000-03-16 WO PCT/CA2000/000289 patent/WO2000055191A2/en not_active Ceased
- 2000-03-16 EP EP09170138A patent/EP2133359A3/en not_active Withdrawn
-
2008
- 2008-03-27 JP JP2008084499A patent/JP2008188018A/ja active Pending
-
2011
- 2011-01-21 JP JP2011011250A patent/JP2011103893A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NZ514606A (en) | 2004-05-28 |
| NZ530979A (en) | 2005-08-26 |
| JP2004529601A (ja) | 2004-09-30 |
| EP2133359A3 (en) | 2010-03-10 |
| WO2000055191A2 (en) | 2000-09-21 |
| AU3268000A (en) | 2000-10-04 |
| AU772007B2 (en) | 2004-04-08 |
| MXPA01009335A (es) | 2003-08-01 |
| CA2364667A1 (en) | 2000-09-21 |
| WO2000055191A3 (en) | 2001-08-02 |
| US6335182B1 (en) | 2002-01-01 |
| DE60037413D1 (de) | 2008-01-24 |
| JP2011103893A (ja) | 2011-06-02 |
| EP1903055A3 (en) | 2008-08-06 |
| EP1180119A2 (en) | 2002-02-20 |
| EP1180119B1 (en) | 2007-12-12 |
| EP2133359A2 (en) | 2009-12-16 |
| DE60037413T2 (de) | 2008-06-19 |
| JP2008188018A (ja) | 2008-08-21 |
| EP1903055A2 (en) | 2008-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69935986D1 (de) | Streptococcus pneumoniae proteine und nukleinsäuren | |
| NZ591415A (en) | Haemophilus influenzae type B | |
| IL197339A0 (en) | Recombinant uricase protein | |
| NZ540544A (en) | Nucleic acids and proteins from streptococcus groups A & B | |
| DE60033138D1 (de) | Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren | |
| AU4981101A (en) | Subtilisin variants | |
| EP1005540A4 (en) | IKK-BETA PROTEINS, NUCLEIC ACIDS AND METHODS | |
| FR2637612B1 (fr) | Sequences de nucleotides codant pour une proteine a activite ureasique | |
| WO2002006457A3 (en) | Novel lipase genes | |
| WO2002008277A3 (en) | Nucleic acids, vectors, host cells, polypeptides, and uses thereof | |
| DE69837475D1 (de) | Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren | |
| ATE380823T1 (de) | Rekombinante adhesin-proteine aus haemophilus influenzae | |
| AU2001238064A1 (en) | 18477, a human protein kinase and uses therefor | |
| AU5727099A (en) | A 2,6-beta-d-fructan hydrolase enzyme and processes for using the enzyme | |
| HK1048495A1 (zh) | 脱氧核糖核酸编码的prost07多肽 | |
| WO2002012475A3 (en) | C1q-related factor, homologous polypeptides and therapeutic uses thereof | |
| ZA200007619B (en) | New peptide fragments for protein purification. | |
| WO2003018806A1 (fr) | Nouveau gene humain bmcc1 | |
| EP1383877A4 (en) | INSULATED HUMAN ENZYMATIC PROTEINS, NUCLEIC ACID MOLECULES ENCODING HUMAN ENZYMATIC PROTEINS, AND USES THEREOF | |
| WO1999050288A3 (en) | Mammalian blood loss-induced gene, kd312 | |
| WO2003020933A1 (fr) | Nouvelle proteine mt0039 inhibitrice de serine protease | |
| DE60143299D1 (de) | Unter salzstress erhöhte expression aufweisende nukleinsäuren und proteine | |
| DE69939989D1 (de) | Menschliches gas-6 (growth arrest-specific gene 6) Protein und dafür kodierende Nukleinsäuren | |
| WO2004058978A3 (en) | Protein purification means | |
| WO2001012788A3 (en) | Tryptase-like polypeptide ztryp1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1180119 Country of ref document: EP |